Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission
Crossref DOI link: https://doi.org/10.1007/s12185-017-2389-8
Published Online: 2017-12-14
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Miyamoto, Toshihiro
Nagafuji, Koji
Fujisaki, Tomoaki
Uchida, Naoyuki
Matsue, Kosei
Henzan, Hideho
Ogawa, Ryosuke
Takase, Ken
Aoki, Takatoshi
Hidaka, Michihiro
Teshima, Takanori
Taniguchi, Shuichi
Akashi, Koichi
Harada, Mine
License valid from 2017-12-14